Fritextsökning
Innehållstyper
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Genombrott för patentlagar i USA
Nu blir det lättare för europeiska företag att söka patent i USA.
-
Dupont gets new business manager
The Swedish API manufacturer Dupont Chemoswed has appointed a new business development manager.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Cykel till Silviahemmet
Brighter inleder samarbete med Silviahemmet genom att erbjuda sin innovation jDome BikeAround till demenshemmets patienter.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Biosimilarer ger prispress, men används de tillräckligt?
Biosimilarernas ankomst för drygt 16 år sedan väckte hopp om att många fler patienter skulle få tillgång till effektiva men annars mycket dyra behandlingar med ...
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Sverige i innovationstoppen
Sverige hamnar på tredje plats i årets Global Innovation Index.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Prisar politiker och Lundaforskare
Riksdagsledamoten Barbro Westerholm och professorn Catharina Svanborg får pris från Forska Sverige.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Stärker analysen med virtual reality
Brighters nya dotterbolag var ett oförskämt kap, enligt vd Truls Sjöstedt.